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Community-acquired methicillin-resistant Staphylococcus
aureus (MRSA) infection has increased as along with
hospital-acquired MRSA all over the world. According
to the US Centers for Disease Control and Prevention
(CDC), the number of MRSA-associated admissions
was 126000 from 1999 to 2000 and the number cases of
invasive MRSA was 94360 cases in 2005, which
brought with it very high associated medical costs [1,2].
In Canada, 8.62 per 1000 admissions in 2007 were MRSA-
associated, and vancomycin-resistant Enterococci (VRE)
was isolated in 1.32 patients per 1000 admissions [3].
MRSA and VRE are typical nosocomial infections and
can be transmitted to healthy individuals via person to
person contact. Thus, MRSA and VRE were designated
as nationally notifiable communicable diseases by the
Korea CDC since 2010 because of their infectivity and
fatality. Tuberculosis (TB) has been a serious public
health problem inducing endemic infection in Korea. In
2007, the incidence rate and mortality rate of TB in Korea
were 71.6 and 5.9 per 100000 persons respectively [4].
The World Health Organization estimated that 9.2
million new cases and 1.7 million deaths from TB
occurred in 2006, of which 0.7 million cases and 0.2
million deaths were in Human immunodeficiency virus-
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Objectives: An ambulance can be a potential source of contagious or droplet infection of a community. We estimated the
prevalence of positive carriage of tuberculosis (TB), methicillin-resistant Staphylococcus aureus (MRSA), and
vancomycin-resistant Enterococci (VRE) in patients transported by ambulance.
Methods: This was a retrospective observational study. We enrolled all patients who visited a tertiary teaching hospital
emergency department (ED). Blood, sputum, urine, body fluid, and rectal swab samples were taken from patients when
they were suspected of TB, MRSA, or VRE in the ED. The patients were categorized into three groups: pre-hospital
ambulance (PA) group; inter-facility ambulance (IA) group; and non-ambulance (NA) group. Adjusted odds ratio (OR) and
95% confidence intervals (CI) were calculated using a multivariable logistic regression model for the prevalence of each
infection.
Results: The total number of patients was 89206. Of these, 9378 (10.5%) and 4799 (5.4%) were in the PA and IA group,
respectively. The prevalence of TB, MRSA, and VRE infection were 0.3%, 1.1%, and 0.3%, respectively. In the PA group,
the prevalence of TB, MRSA, and VRE were 0.3%, 1.8%, and 0.4%. In the IA group, the prevalence of TB, MRSA, and
VRE were 0.7%, 4.6%, and 1.5%, respectively. The adjusted ORs (95% CI) of the PA and IA compared to the NA group
were 1.02 (0.69 to 1.53) and 1.83 (1.24 to 2.71) for TB, 2.24 (1.87 to 2.69) and 5.47 (4.63 to 6.46) for MRSA, 2.59 (1.78 to
3.77) and 8.90 (6.52 to 12.14) for VRE, respectively.
Conclusions: A high prevalence of positive carriage of TB, MRSA, and VRE in patients transported by metropolitan
ambulances was found. 
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positive people globally [5,6]. 
Numerous studies have reported that MRSA and VRE
are common pathogens that can spread from patient to
patient through surface contamination and healthcare
workers [7]. TB can also be easily transmitted via the
respiratory tract causing opportunistic infection,
particularly in immune compromised patients. 
Ambulances can be a potential source of contamination
of various microorganisms because ambulances transport
patients without having a prior knowledge of a patient’s
risk factors, or of the colonization or infection state of the
ambulance. The space of an ambulance is small and
closed, so there may be high probabilities of contami-
nation between persons and between patients and
equipment. A high call volume and lack of sufficient
time for sterilization also make strict infection control
difficult [8]. For these reasons, patients who are
transported by ambulance are very vulnerable to
infection. A high prevalence of infection among patients
who are transported by ambulances is a risk factor of
ongoing community transmission because it can be a
source of infection of the next patient who is transported
by the ambulance. We aimed to estimate the prevalence
of positive carriage of TB, MRSA, and VRE among
patients that present to the emergency department (ED)
by mode of transportation. 
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I. Study Design and Setting
This study was a retrospective observational study
which was a review of patients’ medical records among
those who presented to the ED of one tertiary academic
hospital. This study was reviewed and approved by the
institutional review board of the study coordinating
hospital and granted a waiver of signed informed
consent. 
This study was conducted at one tertiary academic
hospital with 50000 annual visits and a 25% admission
rate of ED visits. Pre-hospital ambulance services are
operated by the fire department, which covers all
emergency delivery. Inter-facility transports usually are
performed by private ambulance companies. Ambulance
crews in one delivery are composed of two or three, who
have the license of emergency medical technician
(EMT)-basic or EMT-intermediate. The ambulance
authorities have their own infection control guidelines,
which are declaratory rather than practical. 
II. Data Collection and Processing 
The patients who visited a study ED from January
2007 to December 2008 were enrolled. Doctors working
in the ED ordered culture studies routinely when the
patients had any sign of infection, such as fever,
hypothermia, hypotension, leukocytosis, or elevation of
c-reactive protein, although there are no standard rules
for ordering cultures. Blood, sputum, urine, body fluid,
and rectal swab samples were taken from patients when
they were suspected of any infection in the ED.
Demographic data were extracted from the National
Emergency Department Information System (NEDIS),
which is a nationwide common registry for emergency
patients. We collected the mode of transport to the ED
from the NEDIS data, and we classified the study
population according to their mode of transportation as
the pre-hospital ambulance group, the inter-facility
ambulance group, and the non-ambulance group. The
microbiologic laboratory data was extracted from the
microbiology registry of the study institute, which
covered all microorganisms identified in ED patients as
well as admitted patients. The data were selected using
the time the sample was dropped off: the samples that
were taken from patients immediately after arrival in the
ED and before admission were included. 
III. Outcome Measures and Data Analysis 
For three microorganisms, the prevalence was
calculated for all patients and for the ambulance
utilization group. We determined the demographics of
the groups, and we modeled the multivariable logistic
regression analysis for the prevalence by the mode of
visit (pre-hospital ambulance and inter-facility
ambulance group) versus non-ambulance group
adjusting for potential confounders. The adjusted odds
ratio (OR) and 95% confidence intervals (CI) were
calculated.
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I. Demographic Findings
The total number of enrolled patients was 89206. Of
these, pre-hospital ambulances and inter-facility
ambulances were used in 10.5% and 5.4% of patients,
respectively. The median age of patients was 58 in the
pre-hospital ambulance group, 62 in the inter-facility
ambulance group, and 39 in the non-ambulance group. :PVOH4VO3PFUBM
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ED mortality was the highest in the inter-facility
ambulance group (7.2%), followed by the pre-hospital
ambulance group (1.9%) and the non-ambulance group
(0.2%) (Table 1).
II. Prevalence of Positive Carriage of TB,
MRSA, and VRE
The prevalence of TB, MRSA, and VRE for all
patients taken together were 0.3%, 1.1%, and 0.3%,
respectively. TB was positive in 0.3% in the pre-
hospital ambulance group and 0.7% in the inter-facility
ambulance group and MRSA was positive in 1.8% in
the pre-hospital ambulance group and 4.6% in the
inter-facility ambulance group. VRE was positive in
0.4% in the pre-hospital ambulance group and 1.5% in
the inter-facility ambulance group. There were
statistical differences of age, gender, insurance, time
and season of visit, and reason for visit between the
positive and negative carriage of TB, MRSA, and VRE
with older age, more ambulance use, and a higher
proportion of disease as reason of visit in the positive
cases (Table 2).
The adjusted ORs (95% CI) for the potential
confounders of the pre-hospital ambulance group and
inter-facility ambulance compared to the non-ambulance
group were 1.02 (0.69 to 1.53) and 1.83 (1.24 to 2.71)
for TB, 2.24 (1.87 to 2.69) and 5.47 (4.63 to 6.46) for
MRSA, and 2.59 (1.78 to 3.77) and 8.90 (6.52 to 12.14)
for VRE, respectively (Table 3).
III. The Identified Source of TB, MRSA, and
VRE
The most commonly identified sources were sputum
(60.5%) for TB, sputum (21.2%) for MRSA, and rectal
swab (39.7%) for VRE (Table 4).
%*4$644*0/
Antibiotic-resistant strains are an increasingly
Table 1. The characteristics of patients visiting the emergency department by type of transportation
p-value Total
Pre-hospital
ambulance
Inter-facility
ambulance
Non-ambulance
Total
Gender
Male
Female
Age (y)
Median (IQR)
Time of visits
8 am to 4 pm
4 pm to MN
MN to 8 am
Season of visits
Spring (Mar-May)
Summer (Jun-Aug)
Fall (Sep-Nov)
Winter (Dec-Feb)
Insurance
National health insurance
Automobile private insurance
Medical aid program
Other
Reason for visit
Disease
Injury
Length of stay in ED (h)
MeanSD
Disposition from ED
Discharge
Transfer
Admission
Death
Other
89206 00()00
47929 (53.7)
41277 (46.3)
44 (18, 63)
41413 (46.4)
32950 (36.9)
14843 (16.6)
23140 (25.9)
22834 (25.6)
21705 (24.3)
21527 (24.1)
80853 (90.6)
1807 (2.0)
4957 (5.6)
1589 (1.8)
74293 (83.3)
14913 (16.7)
6.91.1
63037 (70.7)
2597 (2.9)
22673 (25.4)
0629 (0.7)
0270 (0.3)
9378 00()0
5232 (55.8)
4146 (44.2)
58 (40, 70)
3556 (37.9)
3384 (36.1)
2438 (26.0)
2383 (25.4)
2353 (25.1)
2372 (25.3)
2270 (24.2)
7790 (83.1)
491 (5.2)
696 (7.4)
401 (4.3)
7251 (77.3)
2127 (22.7)
8.116.5
5328 (56.8)
636 (6.8)
3212 (34.3)
174 (1.9)
028 (0.3)
4799 00()00
2751 (57.3)
2048 (42.7)
62 (46, 72)
1998 (41.6)
2020 (42.1)
0781 (16.3)
1173 (24.4)
1282 (26.7)
1158 (24.1)
1186 (24.7)
4300 (89.6)
177 (3.7)
237 (4.9)
085 (1.8)
4010 (83.6)
0789 (16.4)
9.419.2
1120 (23.3)
328 (6.8)
3000 (62.5)
345 (7.2)
006 (0.1)
75029 00()00
39946 (53.2)
35083 (46.8)
39 (13, 61)
35859 (47.8)
27546 (36.7)
11624 (15.5)
19584 (26.1)
19199 (25.6)
18175 (24.2)
18071 (24.1)
68763 (91.6)
1139 (1.5)
4024 (5.4)
1103 (1.5)
63032 (84.0)
11997 (16.0)
6.51.1
56589 (75.4)
1633 (2.2)
16461 (21.9)
0110 (0.1)
0236 (0.3)
<0.01
<0.01
<0.01
0.03
<0.01
<0.01
<0.01
<0.01
Data are presented as n (%).
IQR, inter-quartile range; MN, midnight; STD, standard deviation; ED, emergency department.5#
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Table 2. The characteristics of patients visiting the emergency department by type of infection
% n
Total
% n
Tuberculosis
n% p-value
2 p-value
1
MRSA
% n
VRE
Total
Gender
Male
Female
Age (y)
Median (IQR)
Transportation
Pre-hospital ambulance
Inter-facility ambulance
Non-ambulance
Time of visits
8 am to 4 pm
4 pm to MN
MN to 8 am
Season of visits
Spring (Mar-May)
Summer (Jun-Aug)
Fall (Sep-Nov)
Winter (Dec-Feb)
Insurance
National health insurance
Automobile private insurance
Medical aid program
Other
Reason for visit
Disease
Injury
89206
47929
41277
9378
4799
75029
41413
32950
14843
23140
22834
21705
21527
80853
1807
4957
1589
74293
14913
53.7
46.3
10.5
5.4
84.1
46.4
36.9
16.6
25.9
25.6
24.3
24.1
90.6
2.0
5.6
1.8
83.3
16.7
249
147
102
29
31
189
144
83
22
51
63
85
50
227
0
21
1
244
5
0.3
0.3
0.2
0.3
0.6
0.3
0.3
0.3
0.1
0.2
0.3
0.4
0.2
0.3
0.0
0.4
0.1
0.3
0.0
0.09
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
939
614
325
165
221
553
505
310
124
242
222
254
221
849
11
67
12
892
47
1.1
1.3
0.8
1.8
4.6
0.7
1.2
0.9
0.8
1.0
1.0
1.2
1.0
1.1
0.6
1.4
0.8
1.2
0.3
<0.01
<0.01
<0.01
<0.01
0.22
0.03
<0.01
227
122
105
39
74
114
134
67
26
80
45
36
66
202
2
22
1
212
15
0.3
0.3
0.3
0.4
1.5
0.2
0.3
0.2
0.2
0.3
0.2
0.2
0.3
0.2
0.1
0.4
0.1
0.3
0.1
44 (18, 63) 60 (42, 73) 61 (39, 72) 61 (45, 72)
MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant Enterococci; IQR, inter-quartile range; MN, midnight.
1 p-value is the statistical difference between the positive and negative carriage of tuberculosis.
2 p-value is the statistical difference between the positive and negative carriage of MRSA.
3 p-value is the statistical difference between the positive and negative carriage of VRE.
p-value
3
0.99
<0.01
<0.01
<0.01
<0.01
0.01
<0.01
Table 3. Results of multivariable logistic regression model of tuberculosis, MRSA, and VRE infection by type of transportation
Total (n)
Tuberculosis 95% CI 95% CI
AOR
1
Lower limit Lower limit Upper limit Upper limit
OR
% n
Non-ambulance
Pre-hospital ambulance
Inter-facility ambulance
75029
9378
4799
189
29
31
0.3
0.3
0.6
1.00
1.23
2.58
0.83
1.76
1.82
3.77
1.00
1.02
1.83
0.69
1.24
1.53
2.71
95% CI 95% CI
Lower limit Lower limit Upper limit Upper limit
95% CI 95% CI
Lower limit Lower limit Upper limit Upper limit
95% CI 95% CI
Lower limit Lower limit Upper limit Upper limit
Total (n)
MRSA
AOR
1 OR
% n
Non-ambulance
Pre-hospital ambulance
Inter-facility ambulance
75029
9378
4799
553
165
221
0.7
1.8
4.6
1.00
2.41
6.50
2.02
5.55
2.87
7.62
1.00
2.24
5.47
1.87
4.63
2.69
6.46
Total (n)
VRE
AOR
1 OR
% n
Non-ambulance
Pre-hospital ambulance
Inter-facility ambulance
75029
9378
4799
114
39
74
0.2
0.4
1.5
1.00
2.74
10.29
1.91
7.67
3.95
13.81
1.00
2.59
8.90
1.78
6.52
3.77
12.14
Total (n)
Any of 3 infections
AOR
1 OR
% n
Non-ambulance
Pre-hospital ambulance
Inter-facility ambulance
75029
9378
4799
804
211
290
1.1
2.2
6.0
1.00
2.13
5.94
1.82
5.18
2.48
6.81
1.00
1.95
4.90
1.66
4.24
2.28
5.66
MRSA, methicillin-resistant Staphylococcus aureus, VRE; vancomycin-resistant Enterococci; OR, odds ratio; CI, confidence intervals; AOR, adjusted adds ratio.
1 Adjusted for the gender, age, time of visit, season of visit, insurance, and reason for visit. :PVOH4VO3PFUBM
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common and challenging public health issue in most of
the world. In particular, MRSA is the most common
strain of antibiotics-resistant infection, which varies in
incidence according to geographic area and study
institution. For example, Sweden and Norway reported
less than 1% of MRSA, compared to high proportions in
USA (25% to 50%), Canada (5% to 10%), and Hong
Kong and Singapore (>50%) [9]. VRE was reported at
7% in Germany and 16% in Switzerland and Greece
[10]. In this study population, the overall prevalence of
MRSA and VRE were 0.3% and 1.1%, which is not
high compared to other countries. Although the
incidence rates of TB have declined substantially in the
United States, global efforts for TB control are being
challenged by the steady increase in drug resistant TB,
particularly multidrug resistant TB [11,12]. MRSA and
VRE are also regarded as new challenging issues.
Previous studies have reported that 51% to 59% of
MRSA infections were found in purulent skin and soft
tissue infections [13,14]. MRSA was found to be a
potential risk factor with a 1.9 OR for the contamination
of healthcare workers [13].
Several studies have reported positive MRSA findings
in samples from ambulances [15-19]. These results also
suggested that the patients with positive microorganisms
who were transported by an ambulance could be a
source of contamination of the ambulance. The
ambulances which came into direct contact with patients
were an important reservoir for these organisms.
Furthermore, ambulances which transported the patients
may be a potential risk factor of ongoing community
transmission because it can be a source of infection to
the next patients or ambulance crews who is transported
by the ambulance. Regardless of whether the infection
was community acquired or hospital acquired, therefore,
patients with positive microorganisms who were
transported by an ambulance can be another source of
contamination of the ambulance, healthcare workers,
and community contagion. 
In particular, the inter-facility ambulance patients
showed a much higher prevalence of MRSA and VRE
than that in the ambulatory patients. The adjusted OR for
MRSA of the pre-hospital ambulance group (2.24) was
comparable with other studies, whereas the adjusted OR
for MRSA of the inter-facility ambulance group (5.47)
was very high. Patients who were transported from
another hospital had a higher exposure to an infection
risk of MRSA and VRE. It might be because there was
no infection control program in the private ambulance
services. Moreover, the patients transported between
hospitals are more likely to be elderly and have a chronic
disease or be in critical condition, and thus they are
vulnerable for such infection. To decrease the spread of
MRSA, patients with MRSA transported from another
hospital were recommended to be isolated until being
sterilized [20].
A higher rate of prevalence of MRSA and VRE does not
always suggest that the ambulance is the source of
contamination of community infection. However, these
findings suggest that ambulance transport can be a
potential source for infection for the next patients. To
prevent this contagion, we should develop a strict infection
control program for ambulance crews and services.
For ambulance infection control, the US Standard on
Fire Department Occupational Safety and Health
Program was introduced in 1987 [21,22]. To give enough
ventilation in an ambulance, a strict ventilation time of
1.5 minutes or a high-efficiency particulate arresting filter
was recommended [23]. Many ambulance infection
control programs already suggested guidelines for an in-
depth program for sterilization, decontamination of
material and equipment [23]. However, the actual
adherence to these guidelines or the effect of these
control programs remains unknown. In the setting of the
present study, pre-hospital ambulances are operated by
the fire department while inter-facility ambulances are
operated by private companies or hospitals. According to
the emergency medical service agency or ambulance
authority, adherence to an infection control program
could be variable. We do not know what kinds of
screening and surveillance programs would be effective
for ambulance infection control for each ambulance
configuration. 
Table 4. The identified source of TB, MRSA, and VRE
Data are presented as n (%).
TB, tuberculosis; MRSA, methicillin-resistant Staphylococcus aureus; VRE,
vancomycin-resistant Enterococci.
TB MRSA VRE
Total
Blood, peripheral
Blood, central catheter
Broncho-alveolar lavage
Endotracheal aspiration
Sputum
Nasopharynx, oral
Urine, catheter
Urine, clean-voided
Stool
Rectal swab
Wound, abscess
Skin
Tissue
Body fluid
Drainage
Other
294 (100.0)
1 (0.3)
0 (0.0)
33 (11.2)
21 (7.1)0
178 (60.5)0
2 (0.7)
0 (0.0)
3 (1.0)
1 (0.3)
0 (0.0)
16 (5.4)0
2 (0.7)
15 (5.1)0
21 (7.1)0
1 (0.3)
0 (0.0)
1569 (100.0)
138 (8.8)0
68 (4.3)
34 (2.2)
274 (17.5)
333 (21.2)
86 (5.5)
21 (1.3)
79 (5.0)
00 (0.0)
00 (0.0)
225 (14.3)
49 (3.1)
28 (1.8)
66 (4.2)
141 (9.0)0
27 (1.7)
398 (100.0)
24 (6.0)0
15 (3.8)0
2 (0.5)
0 (0.0)
0 (0.0)
0 (0.0)
23 (5.8)0
64 (16.1)
29 (7.3)0
158 (39.7)0
30 (7.5)0
5 (1.3)
4 (1.0)
18 (4.5)0
21 (5.3)0
5 (1.3)5#
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This study had several limitations. The study was
performed using a retrospective data review, which
might result in the underestimation of the prevalence of
TB, MRSA, and VRE. To determine the exact
prevalence of these infections in the study hospital, we
should test and culture the specimen for all patients of
the study period. We know that the result cannot be
generalized to all EDs because this study was from only
a single tertiary teaching hospital ED. Future research
should investigate the representative incidence and
prevalence rate of across South Korea using data on the
nationally notifiable communicable diseases that is
collected by the Korea CDC. The tremendous efforts
that have been made to improve surveillance of
nosocomial infections like MRSA and VRE would be a
good foundation for establishing preventive and public
health policies. There were differences of severity such
as admission and mortality rate, regardless of type of
disease, between the pre-hospital ambulance group,
inter-facility ambulance group, and non-ambulance
group. The ORs of the ambulance-using groups might be
overestimated if difference of disease severity between
patients would be a potential confounder for positive
carriage of TB, MRSA, and VRE. We could not
conclude that the prevalence of these microorganism
infections was associated with the direct probability of
contamination to other patients using the ambulance;
however, the data suggest that the high prevalence
among patients who transported by ambulances may be
a risk factor of ongoing community transmission
because it can be a potential source of infection to the
next patient who is transported by the ambulance. Future
research should investigate the actual transmission rate
by monitoring suspected cases that use ambulances and
any rate of reduction that follows the initiation of an
infection control program for ambulances. 
In conclusion, ambulances can be a potential source of
MRSA, VRE, and TB contamination. We found a much
higher prevalence of those infections in the patient group
transported from other hospitals, followed by the patient
group transported by prehospital ambulances. Further
study on the effectiveness of infection control programs
should aim to identify the ways prehospital providers
can reduce the risk of transmission of microorganisms
among patients.
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